Hydroxypropyl-β-cyclodextrin: A New Star in Polymer Excipients for Solubility And Stability Challenges

As the pharmaceutical and food industries move towards high-end and refined development, a polymer excipient called "hydroxypropyl-β-cyclodextrin (HP-β-CD)" is increasingly drawing industry attention. With its excellent solubilizing properties, outstanding biological safety, and wide applicability across multiple fields, HP-β-CD is gradually replacing traditional cyclodextrin parent compounds and playing a crucial role in the new industrial wave.

HP-β-CD is an etherified product formed by the reaction of β-cyclodextrin with propylene oxide. Its unique "hydrophilic outer wall and hydrophobic inner cavity" hollow cylindrical structure enables it to efficiently encapsulate lipophilic and poorly soluble drug molecules, thereby significantly enhancing the solubility and stability of the target substances in water. Compared with traditional β-cyclodextrin, the introduction of hydroxypropyl breaks the intramolecular cyclic hydrogen bonds, resulting in a breakthrough improvement in water solubility. It is highly soluble in water or propylene glycol. After encapsulation, the solubility of some poorly soluble drugs can be increased from almost insoluble to a level that meets clinical injection requirements. Additionally, this substance has low toxicity and good biocompatibility. The U.S. Food and Drug Administration has approved its use in the pharmaceutical and food industries, making it a recognized safe and efficient solubilizer for injections and drug excipient.

Currently, HP-β-CD has established three core application tracks: pharmaceuticals, food, and cosmetics. In the pharmaceutical industry, it is widely used in oral liquids, injections, sustained-release and controlled-release preparations, and targeted preparations, improving the bioavailability of poorly soluble drugs, adjusting the drug release rate, and reducing side effects. In the food and flavoring fields, it is used as a stabilizer and encapsulant, not only enhancing the persistence and long-term effectiveness of nutritional molecules but also effectively masking unpleasant odors and tastes in food. In the cosmetics industry, it serves as a stabilizer, emulsifier, and deodorant, reducing the irritation of organic molecules to the skin and mucous membranes, preventing the volatilization and oxidation of nutrients, and significantly improving product quality.

At present, technological exploration in this field has entered a new stage. Recently, new breakthroughs have been made in HP-β-CD encapsulation technology, enabling the safe water-based injection of poorly soluble drugs and providing a new solution to the adverse reactions of traditional oil-based injections. Meanwhile, domestic enterprises are actively laying out high-end production capacity. Companies like Shanhe Pharmaceutical Excipients are accelerating the development of research centers and capacity expansion projects to further enhance their competitiveness in the high-end pharmaceutical excipient market. Industry analysts predict that, against the backdrop of the continuous growth in demand for new drug formulations, functional foods, and high-end cosmetics, the market for HP-β-CD is expected to experience steady growth with promising future prospects.